Results of review by Marwood Group Advisory released by Amedisys

NewsGuard 100/100 Score

Amedisys, Inc. (NASDAQ: AMED)(the “Company”), one of America's leading home health and hospice nursing companies, today released the results of a review conducted by Marwood Group Advisory, LLC (Marwood). Several months ago Amedisys engaged Marwood, one of the nation’s preeminent health care consulting firms, to provide an independent analysis of the Company’s procedures, controls, clinical infrastructure, corporate compliance processes, technology offerings and future strategies. Marwood conducted a review of academic research, over 11,000 pages of Company specific documents, interviews with 18 members of Company leadership, and interviews with a cross section of other home health providers from across the nation, and utilized its home health industry, legislative and regulatory knowledge to measure industry standards, best practices and leading practices to evaluate the Amedisys model and infrastructure. The results showed that Amedisys ranked highest compared to other publicly traded home health companies in terms of quality improvement and compliance processes. Among their findings, Marwood stated, “Amedisys also employs best practices in the areas of field clinician coding and accuracy, oversight and management infrastructure, corporate compliance, and care coordination technology.” They further state, “Based on our Quality and Compliance Process Scorecard and information collected during our review of Company documentation and onsite interviews, Marwood believes that, overall, Amedisys has implemented compliance and quality improvement processes that meet and/or exceed the industry average.”

The entire report has been posted to our website at www.amedisys.com.

“We are pleased with the results that Marwood found in their review of our Company,” stated William F. Borne, Chief Executive Officer. “We operate our Company with a view toward providing clinical excellence for our patients while maintaining effective compliance and controls, and these findings evidence our leadership in these and other measures.”

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
AI-driven advancements in electronic skin technology promise revolution in health monitoring and diagnostics